Monday, January 7, 2013

*  AFTER A STUDY ON OVER 900 PEOPLE, A DRUG RELEASED BY THE FDA FOR TREATMENT OF ALS FAILED TO SHOW THERAPEUTIC VALUE, BIOGEN IDEC WILL STOP PRODUCTION OF DEXPRAMIPEXOLE BECAUSE OF THIS STUDY. THE STUDY WAS CALLED "EMPOWER" BUT HAS CONCLUDED IN A DISAPPOINTMENT.

* IF THE REPORT BY THE CDC IS TRUE, MAJOR INVESTIGATION FOR WRONG DOING IS NEEDED URGENTLY. THE REPORTS SUGGESTS THAT 22 MILLIONS WOMEN WHO HAVE UNDERGONE HYSTERECTOMIES, CONTINUED TO HAVE PAP SMEAR.  WITH A 94 % RATE OF TOTAL HYSTERECTOMY, IT IS SUSPECTED THAT MILLIONS OF WOMEN WERE DUPED!
THE REPORT WAS GENERATED REPORTEDLY BY PHONE INTERVIEWS CONDUCTED BETWEEN 2000 AND 2010.  SCANDAL IS IN THE AIR!  THE DEFENSE FROM THE MEDICAL COMMUNITY: "PHONE INTERVIEW ARE BIASED".

1 comment:

Kalimba said...

Millions of unnecessary PAP smears ... somebody must have cashed in from this Golden-Egg-Goose. Who?
.... maybe somebody will soon start prescribing eyeglasses for the blind and routine contraceptive measures for women over 60 years of age ...